10/17/23 10:06 | 10/13/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S | -5 | 15.10 | 0 | 0 | -1 | 27 | D | | | | | | | | | | | | | | |
10/12/23 11:25 | 10/11/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S | -30 | 15.69 | 0 | -2 | -7 | 26 | D | | | | | | | | | | | | | | |
12/28/21 17:41 | 12/23/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -29 | 44.91 | 0 | -1 | -3 | 21 | D | | | | | | | | | | | | | | |
9/30/21 18:10 | 9/30/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -699 | 43.72 | 0 | -16 | -44 | 20 | D | | | | | | | | | | | | | | |
5/4/21 16:04 | 5/3/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP,Inter | S | -34 | 96.73 | 0 | 0 | -3 | 10 | D | | | | | | | | | | | | | | |
4/14/21 18:07 | 4/13/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP,Inter | S | -92 | 92.25 | 0 | -1 | -9 | 10 | D | | | | | | | | | | | | | | |
2/8/21 14:31 | 2/5/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP,Inter | S | -193 | 85.23 | 0 | -2 | -17 | 11 | D | | | | | | | | | | | | | | |
1/7/21 08:14 | 1/6/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP,Inter | S.d | -914 | 82.91 | 0 | -11 | -45 | 14 | D | | | | | | | | | | | | | | |
11/18/20 18:13 | 11/16/20 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP,Inter | S.d | -1,053 | 73.23 | 0 | -14 | -54 | 12 | D | | | | | | | | | | | | | | |
10/22/20 08:41 | 10/21/20 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -471 | 70.62 | 0 | -7 | -39 | 10 | D | | | | | | | | | | | | | | |
8/7/20 10:40 | 8/5/20 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -455 | 80.08 | 0 | -6 | -35 | 10 | D | | | | | | | | | | | | | | |
5/7/20 17:24 | 5/5/20 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S | -57 | 64.00 | 0 | -1 | -8 | 10 | D | | | | | | | | | | | | | | |
2/14/20 17:11 | 2/14/20 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -517 | 72.75 | 0 | -7 | -39 | 11 | D | | | | | | | | | | | | | | |
2/12/20 15:29 | 2/10/20 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -498 | 70.01 | 0 | -7 | -41 | 10 | D | | | | | | | | | | | | | | |
2/7/20 16:50 | 2/5/20 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.dm | -376 | 70.02 | 0 | -5 | -34 | 10 | D | | | | | | | | | | | | | | |
11/25/19 08:57 | 11/21/19 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -162 | 64.61 | 0 | -3 | -19 | 10 | D | | | | | | | | | | | | | | |
10/17/19 18:24 | 10/16/19 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -183 | 65.89 | 0 | -3 | -21 | 10 | D | | | | | | | | | | | | | | |